SI
TEVA icon

Stephens Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Stephens Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Hold
11,803
– – ﹤0.01% 968
2026
Q1 		$356K Hold
11,803
– – ﹤0.01% 972
2025
Q4 		$368K Sell
11,803
-380
-3% -$9.36K ﹤0.01% 959
2025
Q3 		$246K Sell
12,183
-45
-0.4% -$790 ﹤0.01% 1133
2025
Q2 		$205K Sell
12,228
-20
-0.2% -$323 ﹤0.01% 1163
2025
Q1 		$188K Sell
12,248
-550
-4% -$9.82K ﹤0.01% 1146
2024
Q4 		$282K Sell
12,798
-330
-3% -$6K ﹤0.01% 1044
2024
Q3 		$237K Sell
13,128
-24
-0.2% -$420 ﹤0.01% 1129
2024
Q2 		$214K Buy
13,152
+672
+5% +$10.3K ﹤0.01% 1135
2024
Q1 		$176K Sell
12,480
-200
-2% -$2.52K ﹤0.01% 1179
2023
Q4 		$132K Buy
12,680
+25
+0.2% +$233 ﹤0.01% 1136
2023
Q3 		$129K Sell
12,655
-100
-0.8% -$931 ﹤0.01% 1088
2023
Q2 		$96K Buy
12,755
+100
+0.8% +$811 ﹤0.01% 1129
2023
Q1 		$112K Sell
12,655
-50
-0.4% -$494 ﹤0.01% 1084
2022
Q4 		$116K Buy
12,705
+50
+0.4% +$436 ﹤0.01% 1066
2022
Q3 		$102K Sell
12,655
-760
-6% -$6.72K ﹤0.01% 1098
2022
Q2 		$101K Hold
13,415
– – ﹤0.01% 1127
2022
Q1 		$126K Buy
+13,415
New +$112K ﹤0.01% 1211
2019
Q3 		– Sell
-17,803
Closed -$164K – 1202
2019
Q2 		$164K Sell
17,803
-12,885
-42% -$155K ﹤0.01% 1097
2019
Q1 		$481K Sell
30,688
-3,761
-11% -$66.3K 0.01% 767
2018
Q4 		$531K Sell
34,449
-3,186
-8% -$65.3K 0.02% 687
2018
Q3 		$811K Buy
37,635
+1,035
+3% +$24K 0.02% 641
2018
Q2 		$890K Buy
36,600
+786
+2% +$16K 0.03% 503
2018
Q1 		$612K Sell
35,814
-999
-3% -$19.5K 0.02% 469
2017
Q4 		$698K Buy
36,813
+4,381
+14% +$65.9K 0.03% 430
2017
Q3 		$571K Sell
32,432
-4,579
-12% -$103K 0.02% 464
2017
Q2 		$1.23M Buy
37,011
+13,898
+60% +$430K 0.04% 384
2017
Q1 		$742K Buy
23,113
+7,620
+49% +$260K 0.03% 481
2016
Q4 		$562K Sell
15,493
-27
-0.2% -$1.08K 0.02% 471
2016
Q3 		$714K Buy
15,520
+6,199
+67% +$323K 0.03% 431
2016
Q2 		$468K Sell
9,321
-1,533
-14% -$81.6K 0.02% 503
2016
Q1 		$581K Sell
10,854
-2,098
-16% -$123K 0.03% 436
2015
Q4 		$850K Sell
12,952
-2,361
-15% -$146K 0.04% 353
2015
Q3 		$865K Sell
15,313
-445
-3% -$28.9K 0.05% 356
2015
Q2 		$931K Sell
15,758
-2,907
-16% -$179K 0.04% 376
2015
Q1 		$1.16M Buy
18,665
+1,945
+12% +$113K 0.05% 327
2014
Q4 		$962K Buy
16,720
+1,546
+10% +$86.1K 0.05% 346
2014
Q3 		$816K Sell
15,174
-12,857
-46% -$681K 0.04% 374
2014
Q2 		$1.47M Sell
28,031
-2,905
-9% -$148K 0.07% 268
2014
Q1 		$1.64M Buy
30,936
+4,549
+17% +$210K 0.09% 243
2013
Q4 		$1.06M Buy
26,387
+13,540
+105% +$533K 0.05% 320
2013
Q3 		$485K Sell
12,847
-731
-5% -$28.5K 0.03% 473
2013
Q2 		$532K Buy
+13,578
New +$529K 0.03% 408

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Stephens Inc's TEVA Position: Q2 2026 in Review

Stephens Inc held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 11,803 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Stephens Inc first reported a position in TEVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.64M in Q1 2014. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Stephens Inc held 11,803 shares of Teva Pharmaceuticals worth $400K as of Q2 2026.
  • Stephens Inc left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Stephens Inc's portfolio in Q2 2026, its #968 holding.
  • Stephens Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
  • Stephens Inc's Teva Pharmaceuticals position peaked at $1.64M in Q1 2014.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.